Diaitasure Global Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-01-2025
- Paid Up Capital ₹ 1.00 M
as on 07-01-2025
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 07-01-2025
- Revenue %
(FY 2022)
- Profit -369.57%
(FY 2022)
- Ebitda -801.77%
(FY 2022)
- Net Worth -7.58%
(FY 2022)
- Total Assets 480.31%
(FY 2022)
About Diaitasure Global
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 M.
Vikash Srivastava and Amit Shrivastava serve as directors at the Company.
- CIN/LLPIN
U51900MH2019PTC322738
- Company No.
322738
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Diaitasure Global?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikash Srivastava  | Managing Director | 08-Aug-2022 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Shrivastava | Director | 08-Jan-2021 | Current |
Financial Performance of Diaitasure Global.
Diaitasure Global Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 369.57% decrease in profit. The company's net worth dipped by a decrease of 7.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diaitasure Global?
Unlock access to Diaitasure Global's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Z Pharmaceutical Global Private LimitedActive 1 year 11 months
Vikash Srivastava and Amit Shrivastava are mutual person
- G. D. Financial Solutions Private LimitedActive 15 years 6 months
Amit Shrivastava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Aug 2024 | ₹2.00 M | Open |
How Many Employees Work at Diaitasure Global?
Unlock and access historical data on people associated with Diaitasure Global, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diaitasure Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diaitasure Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
